Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Front Psychol ; 14: 1291851, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38078217

RESUMEN

Background: Improving job performance has a significant effect on the quality of medical services and ensuring people's health. Purpose: This study explores the influence and mechanism of the character strengths and career callings of medical staff as well as the intermediary role of such career calling. Methodology: A cross-sectional survey was conducted of 414 healthcare staff members in public hospitals in Hangzhou. Descriptive statistics and hierarchical linear regressions were used to analyze the medical staff's job performance and related factors, and structural equation modeling path analysis was used to explore and validate the influence and mechanism of character advantage and career calling on job performance. Results: The results show that medical staff character strengths have a positive impact on job performance. Path analysis shows that character strengths indirectly affect job performance, and career calling plays a partial mediating role in character strengths and job performance. Conclusion: The results show that good personalities promote job performance, and the association is more significant under a high sense of career calling.

2.
Eur J Med Chem ; 176: 135-148, 2019 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-31102934

RESUMEN

Angiogenesis plays an essential role in tumourigenesis and tumour progression, and anti-angiogenesis therapies have shown promising antitumour effects in solid tumours. 2-Methoxyestradiol (2ME2), an endogenous metabolite of estradiol, has been regarded as a potential antitumour agent mainly targeting angiogenesis. Here we synthesized a novel series of chalcones based on 2-methoxyestradiol and evaluated their potential activities against tumours. Compound 11e was demonstrated to have potent antiangiogenic activity. Further studies showed that 11e suppressed tumour growth in human breast cancer (MCF-7) xenograft models without obvious side effects. Evaluation of the mechanism revealed that 11e targeted the epithelial to mesenchymal transition (EMT) process in MCF-7 cells and inhibited HUVEC migration and then contributed to hindrance of angiogenesis. Thus, 11e may be a promising antitumour agent with excellent efficacy and low toxicity.


Asunto(s)
2-Metoxiestradiol/análogos & derivados , 2-Metoxiestradiol/uso terapéutico , Inhibidores de la Angiogénesis/uso terapéutico , Antineoplásicos/uso terapéutico , Chalconas/uso terapéutico , Transición Epitelial-Mesenquimal/efectos de los fármacos , 2-Metoxiestradiol/síntesis química , 2-Metoxiestradiol/toxicidad , Inhibidores de la Angiogénesis/síntesis química , Inhibidores de la Angiogénesis/química , Inhibidores de la Angiogénesis/toxicidad , Animales , Antineoplásicos/síntesis química , Antineoplásicos/química , Antineoplásicos/toxicidad , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Chalconas/síntesis química , Chalconas/química , Chalconas/toxicidad , Pollos , Membrana Corioalantoides/efectos de los fármacos , Femenino , Células Endoteliales de la Vena Umbilical Humana , Humanos , Masculino , Ratones Desnudos , Receptores de Factores de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Estereoisomerismo , Ensayos Antitumor por Modelo de Xenoinjerto
3.
Steroids ; 128: 6-14, 2017 12.
Artículo en Inglés | MEDLINE | ID: mdl-29031938

RESUMEN

A series of 17ß-amide-2-methoxyestradiol compounds were synthesized with an aim to enhance the antiproliferative effect of 2-methoxyestradiol. The antiproliferative activity of 2-methoxyestradiol analogs against human cancer cells was investigated. 2-methoxy-3-benzyloxy-17ß-chloroacetamide-1,3,5(10)-triene (5e) and 2-methoxy-3-hydroxy-17ß-butyramide-1,3,5(10)-triene (6c) had comparable or better antitumor activity than 2-methoxyestradiol. The elimination half-life of 6c (t1/2ß=240.93min) is ten times longer than 2-ME and the area under the curve was seven times (AUC0-tmin=2068.20±315.74µgmL-1min) higher than 2-ME, respectively. Whereas 5e had similar pharmacokinetic behavior with 2-ME (t1/2ß=22.28min) with a t1/2ß of 29.5 min. 6c had higher blood concentration, longer actuation duration and better suppression rate against S180 mouse ascites tumor than 2-methoxyestradiol.


Asunto(s)
Proliferación Celular/efectos de los fármacos , Estradiol/análogos & derivados , Neoplasias/tratamiento farmacológico , 2-Metoxiestradiol , Animales , Diseño de Fármacos , Estradiol/administración & dosificación , Estradiol/síntesis química , Estradiol/química , Estradiol/farmacocinética , Humanos , Células MCF-7 , Ratones
4.
J Pharm Pharmacol ; 68(7): 941-52, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27139338

RESUMEN

OBJECTIVES: The aim of this study was to investigate the cardioprotective effect of salvianolic acid B (Sal B) on acute myocardial infarction (AMI) in rats and its potential mechanisms. METHODS: The AMI model was established in rats to study the effect of Sal B on AMI. Haematoxylin-eosin (HE) staining was used to evaluate the pathological change in AMI rats. Immunofluorescence and TUNEL staining were used to detect autophagy and apoptosis of myocardial cells in hearts of AMI rats, respectively. Protein expression of apoptosis-related, autophagy-related and angiogenesis-related proteins were examined by Western blot. KEY FINDINGS: Sal B attenuated myocardial infarction significantly compared with that of the model group. Rats administered with Sal B showed higher inhibition rate of infarction and lower infarct size than those of the model group. Moreover, Sal B decreased the serum levels of creatine kinase, lactate dehydrogenase and malondialdehyde, while increased such level of superoxide dismutase significantly compared with those of the model group. Sal B inhibited the expression of Bax, cleaved caspase-9 and cleaved PARP, while promoted the expression of Bcl-2, LC3-II, Beclin1 and VEGF. CONCLUSIONS: Sal B has cardioprotective effect on AMI and Sal B may be a promising candidate for AMI treatment.


Asunto(s)
Inductores de la Angiogénesis/farmacología , Apoptosis/efectos de los fármacos , Autofagia/efectos de los fármacos , Benzofuranos/farmacología , Cardiotónicos/farmacología , Infarto del Miocardio/prevención & control , Neovascularización Fisiológica/efectos de los fármacos , Animales , Proteínas Reguladoras de la Apoptosis/biosíntesis , Beclina-1/biosíntesis , Creatina Quinasa/sangre , L-Lactato Deshidrogenasa/sangre , Masculino , Malondialdehído/sangre , Proteínas Asociadas a Microtúbulos/biosíntesis , Infarto del Miocardio/metabolismo , Infarto del Miocardio/patología , Infarto del Miocardio/fisiopatología , Miocardio/metabolismo , Miocardio/patología , Ratas , Superóxido Dismutasa/sangre , Factor A de Crecimiento Endotelial Vascular/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...